pyridyldithioethylamine has been researched along with thapsigargin in 1 studies
| Studies (pyridyldithioethylamine) | Trials (pyridyldithioethylamine) | Recent Studies (post-2010) (pyridyldithioethylamine) | Studies (thapsigargin) | Trials (thapsigargin) | Recent Studies (post-2010) (thapsigargin) |
|---|---|---|---|---|---|
| 11 | 0 | 1 | 5,234 | 3 | 918 |
| Protein | Taxonomy | pyridyldithioethylamine (IC50) | thapsigargin (IC50) |
|---|---|---|---|
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bevers, EM; Comfurius, P; Schlegel, RA; Smeets, EF; Williamson, P; Zwaal, RF | 1 |
1 other study(ies) available for pyridyldithioethylamine and thapsigargin
| Article | Year |
|---|---|
Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets.
Topics: 4-Chloro-7-nitrobenzofurazan; Blood Platelets; Calcium; Disulfides; Dithionite; Egtazic Acid; Humans; Ionomycin; Kinetics; Lipid Bilayers; Membrane Lipids; Oxidation-Reduction; Phosphatidylserines; Platelet Activation; Pyridines; Terpenes; Thapsigargin; Thrombin | 1995 |